-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Qube Research & Technologies Ltd Acquires 9,069 Shares of Semler Scientific, Inc. (OTCMKTS:SMLR)
Qube Research & Technologies Ltd Acquires 9,069 Shares of Semler Scientific, Inc. (OTCMKTS:SMLR)
Qube Research & Technologies Ltd increased its stake in Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating) by 86.7% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,525 shares of the medical equipment provider's stock after acquiring an additional 9,069 shares during the quarter. Qube Research & Technologies Ltd owned 0.29% of Semler Scientific worth $968,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of SMLR. Wasatch Advisors Inc. acquired a new position in shares of Semler Scientific during the fourth quarter valued at about $10,898,000. Invenire Partners LP acquired a new position in shares of Semler Scientific during the fourth quarter valued at about $4,456,000. Anchor Capital Advisors LLC acquired a new position in shares of Semler Scientific during the first quarter valued at about $1,573,000. Adirondack Retirement Specialists Inc. increased its position in shares of Semler Scientific by 59.4% during the first quarter. Adirondack Retirement Specialists Inc. now owns 48,933 shares of the medical equipment provider's stock worth $2,546,000 after acquiring an additional 18,226 shares in the last quarter. Finally, Dimensional Fund Advisors LP bought a new stake in shares of Semler Scientific during the fourth quarter worth about $1,552,000. Institutional investors and hedge funds own 44.69% of the company's stock.
Get Semler Scientific alerts:Analysts Set New Price Targets
Separately, B. Riley decreased their target price on shares of Semler Scientific from $70.00 to $60.00 in a research report on Tuesday, May 3rd.
Semler Scientific Stock Down 2.5 %
Semler Scientific stock opened at $43.02 on Thursday. The company has a market capitalization of $292.23 million, a P/E ratio of 26.72 and a beta of 0.89. The firm has a 50 day moving average price of $32.51 and a 200-day moving average price of $43.34. Semler Scientific, Inc. has a twelve month low of $27.02 and a twelve month high of $153.21.Semler Scientific Company Profile
(Get Rating)
Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Recommended Stories
- Get a free copy of the StockNews.com research report on Semler Scientific (SMLR)
- Which Semiconductor Stocks Are Ready For Big Price Moves?
- Miners Advance On Earnings Despite Broader Economic Challenges
- Lowe's Stands Out Amid Q2 Retail Reports
- Agilent Technologies Proves Its Worth VS Illumina
- Target's Results Cap Upside Potential For Retail Stocks
Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating).
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
Qube Research & Technologies Ltd increased its stake in Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating) by 86.7% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,525 shares of the medical equipment provider's stock after acquiring an additional 9,069 shares during the quarter. Qube Research & Technologies Ltd owned 0.29% of Semler Scientific worth $968,000 at the end of the most recent reporting period.
根据Qube Research&Technologies Ltd最近提交给美国证券交易委员会(Securities&Exchange Commission)的13F文件,该公司在第一季度增持了Semler Science,Inc.(场外交易市场代码:SMLR-GET评级)的股份86.7%。该机构投资者在本季度额外收购了9,069股后,持有这家医疗设备提供商的19,525股股票。在最近的报告期结束时,Qube Research&Technologies Ltd拥有Semler Science 0.29%的股份,价值96.6万美元。
A number of other institutional investors also recently modified their holdings of SMLR. Wasatch Advisors Inc. acquired a new position in shares of Semler Scientific during the fourth quarter valued at about $10,898,000. Invenire Partners LP acquired a new position in shares of Semler Scientific during the fourth quarter valued at about $4,456,000. Anchor Capital Advisors LLC acquired a new position in shares of Semler Scientific during the first quarter valued at about $1,573,000. Adirondack Retirement Specialists Inc. increased its position in shares of Semler Scientific by 59.4% during the first quarter. Adirondack Retirement Specialists Inc. now owns 48,933 shares of the medical equipment provider's stock worth $2,546,000 after acquiring an additional 18,226 shares in the last quarter. Finally, Dimensional Fund Advisors LP bought a new stake in shares of Semler Scientific during the fourth quarter worth about $1,552,000. Institutional investors and hedge funds own 44.69% of the company's stock.
其他一些机构投资者最近也调整了对SMLR的持股。Wasatch Advisors Inc.在第四季度收购了Semler Science的新头寸,价值约10,898,000美元。Invenire Partners LP在第四季度收购了Semler Science的新头寸,价值约4,456,000美元。Anch Capital Advisors LLC在第一季度收购了Semler Science的新头寸,价值约1,573,000美元。阿迪朗达克退休专家公司在第一季度将其在Semler Science的股票头寸增加了59.4%。阿迪朗达克退休专家公司目前持有这家医疗设备提供商48,933股股票,价值2,546,000美元,该公司在上个季度增持了18,226股。最后,Dimension Fund Advisors LP在第四季度购买了Semler Science价值约1,552,000美元的新股。机构投资者和对冲基金持有该公司44.69%的股票。
Analysts Set New Price Targets
分析师设定新的价格目标
Separately, B. Riley decreased their target price on shares of Semler Scientific from $70.00 to $60.00 in a research report on Tuesday, May 3rd.
另外,B.莱利在5月3日星期二的一份研究报告中将Semler Science的目标股价从70.00美元下调至60.00美元。
Semler Scientific Stock Down 2.5 %
塞姆勒科学类股下跌2.5%
Semler Scientific Company Profile
赛姆勒科学公司简介
(Get Rating)
(获取评级)
Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Semler Science,Inc.提供技术解决方案,以提高美国医疗保健提供者的临床效果和效率。该公司的产品包括QuantaFlo,这是一种四分钟的办公室内血液流动测试,使医疗保健提供者能够使用血流测量作为患者血管状况检查的一部分。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Semler Scientific (SMLR)
- Which Semiconductor Stocks Are Ready For Big Price Moves?
- Miners Advance On Earnings Despite Broader Economic Challenges
- Lowe's Stands Out Amid Q2 Retail Reports
- Agilent Technologies Proves Its Worth VS Illumina
- Target's Results Cap Upside Potential For Retail Stocks
- 免费获取StockNews.com关于Semler Science(SMLR)的研究报告
- 哪些半导体类股准备好迎接价格大幅波动?
- 尽管面临更广泛的经济挑战,矿商的收益仍在上涨
- Lowe‘s在第二季度零售报告中脱颖而出
- 安捷伦科技对Illumina证明了自己的价值
- 塔吉特的业绩上限零售类股的上行潜力
Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating).
想看看其他对冲基金持有SMLR的情况吗?访问HoldingsChannel.com获取Semler Science,Inc.(OTCMKTS:SMLR-GET Rating)的最新13F文件和内幕交易。
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
接受《塞姆勒科技日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Semler Science及相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧